Some men with advanced prostate cancer who have exhausted all other treatment options could live for two years or more on immunotherapy, a major clinical trial has shown. Researchers found that a small proportion of men were 'super responders' and were alive and well even after the trial had ended despite having had a very poor prognosis before treatment.
from Diseases and Conditions News -- ScienceDaily https://ift.tt/37WTi6f
Sunday, 1 December 2019
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment